Skip to main content
Alligator Bioscience logo

Alligator Bioscience — Investor Relations & Filings

Ticker · ATORX ISIN · SE0024173637 LEI · 549300E15VI0MB7LXV19 ST Manufacturing
Open in API
Filings indexed 608 across all filing types
Latest filing 2025-06-30 Declaration of Voting R…
Country SE Sweden
Listing ST ATORX

About Alligator Bioscience

https://alligatorbioscience.se/en/

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.

Recent filings

Filing Released Lang Actions
Ändring av antalet aktier och röster i Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement in Swedish titled "ÄNDRING AV ANTALET AKTIER OCH RÖSTER I ALLIGATOR BIOSCIENCE AB" (Change in the number of shares and votes in Alligator Bioscience AB). It explicitly states that the total number of shares and votes has changed due to the exercise of warrants and directed new issues of common stock, concluding with the final count as of June 30, 2025. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and appears to be the primary announcement, not just a notice about another report, thus SHA is preferred over RPA/RNS.
2025-06-30 Swedish
Change in number of shares and votes in Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces a 'CHANGE IN NUMBER OF SHARES AND VOTES' due to the exercise of warrants and directed new share issues. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and appears to be a regulatory announcement detailing the resulting share count, not a comprehensive report.
2025-06-30 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage ('Innehavare', 'Andel', '5,28763 %') by an entity ('Nordnet Pensionsförsäkring AB') in Alligator Bioscience AB, specifically noting a 'Köp' (Buy) transaction and referencing thresholds ('Gränsvärde för antal aktier 5 %'). This structure, involving reporting changes in significant share ownership that cross specific percentage thresholds, directly corresponds to the definition of a Major Shareholding Notification. The Swedish context and the nature of the data strongly align with filings tracking insider or significant investor positions, which maps to the 'MRQ' (Major Shareholding Notification) code in the provided schema.
2025-06-26 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Innehavare', 'Transaktionen', 'Antal aktier', 'Andel') by an entity (Nordnet AB (publ)) in Alligator Bioscience AB, specifically noting a 'Köp' (Buy) transaction that caused their holding to cross the 5% threshold ('Gränsvärde för antal aktier 5 %'). This type of mandatory disclosure regarding significant changes in ownership of shares or voting rights is classified as a Major Shareholding Notification. In the provided schema, 'MRQ' (Major Shareholding Notification) is the most appropriate fit for this type of insider/significant shareholder transaction disclosure, which is distinct from Director's Dealing (DIRS) or general Transaction in Own Shares (POS).
2025-06-25 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage ('Innehavare', 'Andel', 'Aktier') by an entity (Nordnet AB (publ)) in Alligator Bioscience AB, specifically noting a 'Sälj' (Sell) transaction and reporting the resulting ownership percentage (4.95097%) which crosses or is near a threshold (5%). This structure, involving reporting changes in significant share ownership, directly corresponds to the definition of a Major Shareholding Notification. In the provided list, this aligns best with the 'Major Shareholding Notification' code (MRQ). The document is a formal regulatory disclosure of insider/significant shareholder activity, not a general earnings release, annual report, or management presentation.
2025-06-23 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage ('Andel innehavda aktier: 5,01006 %') by an entity ('Nordnet AB (publ)') in 'Alligator Bioscience AB'. It specifies the date of the transaction (2025-06-17), the threshold crossed (5%), and the resulting total number of shares and voting rights. This structure is characteristic of a Major Shareholding Notification, where an investor reports crossing a significant ownership threshold, often mandated by financial regulatory authorities (implied by the reference to 'LHF' and 'FI' in the footnotes, suggesting Swedish regulation). This directly matches the definition for Major Shareholding Notification (MRQ).
2025-06-19 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.